Home
>
National Drug Code (NDC)
>
levocetirizine dihydrochloride
levocetirizine dihydrochloride - 0955-1026-21 - (levocetirizine dihydrochloride)
Drug Information of levocetirizine dihydrochloride
| Product NDC: | 0955-1026 |
| Proprietary Name: | levocetirizine dihydrochloride |
| Non Proprietary Name: | levocetirizine dihydrochloride |
| Active Ingredient(s): | .5 mg/mL & nbsp; levocetirizine dihydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of levocetirizine dihydrochloride
| Product NDC: | 0955-1026 |
| Labeler Name: | Winthrop U.S. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022157 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080402 |
Package Information of levocetirizine dihydrochloride
| Package NDC: | 0955-1026-21 |
| Package Description: | 148 mL in 1 BOTTLE, PLASTIC (0955-1026-21) |
NDC Information of levocetirizine dihydrochloride
| NDC Code | 0955-1026-21 |
| Proprietary Name | levocetirizine dihydrochloride |
| Package Description | 148 mL in 1 BOTTLE, PLASTIC (0955-1026-21) |
| Product NDC | 0955-1026 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | levocetirizine dihydrochloride |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20080402 |
| Marketing Category Name | NDA |
| Labeler Name | Winthrop U.S. |
| Substance Name | LEVOCETIRIZINE DIHYDROCHLORIDE |
| Strength Number | .5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
